Morning Overview on MSN
AI blood test spots early pancreatic cancer with up to 94% accuracy
Researchers at Academia Sinica and National Taiwan University Hospital have developed an AI-powered blood test that detects early-stage pancreatic cancer with near-perfect accuracy in validation ...
As healthcare systems worldwide grapple with rising cancer rates, chronic diseases and limited clinical resources, ...
Protein Biomarkers May Play an Important Role in Overcoming Limitations of Circulating Tumor DNA for Screening Early-Stage CancersGAITHERSBURG, M.D., March 12, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs ...
Gene Solutions announced its strategic entry into the Turkish market at the 2nd International Hereditary Cancers Congress (IHCC), held 05–08 February ...
ClearNote Health's enhanced Avantect Pancreatic Cancer Test features industry-leading detection sensitivity and specificity ...
A machine learning-driven eNose detects ovarian cancer in blood plasma with 97 % sensitivity and specificity, offering a promising biomarker-agnostic approach.
Discover how AI healthcare technology and machine learning diagnosis are transforming disease detection, improving accuracy, and reshaping patient care in today's evolving medical landscape.
New research shows an AI-driven liquid biopsy analyzing genome-wide cfDNA fragment patterns can detect early liver fibrosis & cirrhosis and may signal broader chronic disease burden.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results